UPDATE: Qiagen's Q4 Revenues Rise 4 Percent | GenomeWeb

The story has been updated to include comments from Qiagen's conference call this morning.

NEW YORK (GenomeWeb News) – Qiagen said after the close of the market on Tuesday that its fourth-quarter revenues increased 4 percent year over year at constant exchange rates.

For the three months ended Dec. 31, 2012, the firm posted $346.5 million in revenues, up from $334.4 a year ago and surpassing the consensus Wall Street estimate of $327.8 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.